{"count": 11, "results": [{"_id": "2849471", "pmid": 2849471, "title": "Lisinopril pharmacokinetics in chronic renal failure.", "journal": "Br J Clin Pharmacol", "authors": ["Jackson B", "Cubela RB", "Conway EL", "Johnston CI"], "date": "1988-06-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1988.tb05258.x", "meta_date_publication": "1988 Jun", "meta_volume": "25", "meta_issue": "6", "meta_pages": "719-24", "score": 50092.766, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ pharmacokinetics in @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@.", "citations": {"NLM": "Jackson B, Cubela RB, Conway EL, Johnston CI. Lisinopril pharmacokinetics in chronic renal failure. Br J Clin Pharmacol. 1988 Jun;25(6):719-24. PMID: 2849471", "BibTeX": "@article{2849471, title={Lisinopril pharmacokinetics in chronic renal failure.}, author={Jackson B and Cubela RB and Conway EL and Johnston CI}, journal={Br J Clin Pharmacol}, volume={25}, number={6}, pages={719-24}}"}}, {"_id": "2485055", "pmid": 2485055, "title": "Treatment of hypertension with lisinopril in end-stage renal failure.", "journal": "J Cardiovasc Pharmacol", "authors": ["Küntziger HE", "Pouthier D", "Bellucci A"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198706107-00035", "meta_date_publication": "1987", "meta_volume": "10 Suppl 7", "meta_issue": "", "meta_pages": "S157-9", "score": 50080.875, "text_hl": "Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@end-stage renal failure@@@.", "citations": {"NLM": "Küntziger HE, Pouthier D, Bellucci A. Treatment of hypertension with lisinopril in end-stage renal failure. J Cardiovasc Pharmacol. 1987;10 Suppl 7():S157-9. PMID: 2485055", "BibTeX": "@article{2485055, title={Treatment of hypertension with lisinopril in end-stage renal failure.}, author={Küntziger HE and Pouthier D and Bellucci A}, journal={J Cardiovasc Pharmacol}, volume={10 Suppl 7}, pages={S157-9}}"}}, {"_id": "8389563", "pmid": 8389563, "title": "Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.", "journal": "Am J Hypertens", "authors": ["August P", "Lenz T", "Laragh JH"], "date": "1993-04-01T00:00:00Z", "doi": "10.1093/ajh/6.4s.148s", "meta_date_publication": "1993 Apr", "meta_volume": "6", "meta_issue": "4", "meta_pages": "148S-154S", "score": 50065.945, "text_hl": "Comparative renal hemodynamic effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@, and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@.", "citations": {"NLM": "August P, Lenz T, Laragh JH. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure. Am J Hypertens. 1993 Apr;6(4):148S-154S. PMID: 8389563", "BibTeX": "@article{8389563, title={Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.}, author={August P and Lenz T and Laragh JH}, journal={Am J Hypertens}, volume={6}, number={4}, pages={148S-154S}}"}}, {"_id": "2853960", "pmid": 2853960, "title": "Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.", "journal": "Br J Clin Pharmacol", "authors": ["Kelly JG", "Doyle GD", "Carmody M", "Glover DR", "Cooper WD"], "date": "1988-12-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1988.tb05319.x", "meta_date_publication": "1988 Dec", "meta_volume": "26", "meta_issue": "6", "meta_pages": "781-6", "score": 50063.457, "text_hl": "...1. @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ were administered as 2.5 mg single doses and as eight single daily 2.5 mg doses to separate groups of six @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@. ", "citations": {"NLM": "Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. Br J Clin Pharmacol. 1988 Dec;26(6):781-6. PMID: 2853960", "BibTeX": "@article{2853960, title={Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.}, author={Kelly JG and Doyle GD and Carmody M and Glover DR and Cooper WD}, journal={Br J Clin Pharmacol}, volume={26}, number={6}, pages={781-6}}"}}, {"_id": "9488243", "pmid": 9488243, "title": "The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.", "journal": "J Hypertens", "authors": ["Campo C", "Garcia-Vallejo O", "Barrios V", "Lahera V", "Manero M", "Esteban E", "Rodicio JL", "Ruilope LM"], "date": "1997-12-01T00:00:00Z", "doi": "10.1097/00004872-199715120-00093", "meta_date_publication": "1997 Dec", "meta_volume": "15", "meta_issue": "12 Pt 2", "meta_pages": "1803-8", "score": 50052.32, "text_hl": "OBJECTIVE: To compare the natriuretic capacity of @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ gastrointestinal therapeutic system (GITS) and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @SPECIES_9606 @@@patients@@@ with mild-to-moderate @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@. ", "citations": {"NLM": "Campo C, Garcia-Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, Rodicio JL, Ruilope LM. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure. J Hypertens. 1997 Dec;15(12 Pt 2):1803-8. PMID: 9488243", "BibTeX": "@article{9488243, title={The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.}, author={Campo C and Garcia-Vallejo O and Barrios V and Lahera V and Manero M and Esteban E and Rodicio JL and Ruilope LM}, journal={J Hypertens}, volume={15}, number={12 Pt 2}, pages={1803-8}}"}}, {"_id": "18496513", "pmid": 18496513, "title": "Fat redistribution and adipocyte transformation in uninephrectomized rats.", "journal": "Kidney Int", "authors": ["Zhao HL", "Sui Y", "Guan J", "He L", "Zhu X", "Fan RR", "Xu G", "Kong AP", "Ho CS", "Lai FM", "Rowlands DK", "Chan JC", "Tong PC"], "date": "2008-08-01T00:00:00Z", "doi": "10.1038/ki.2008.195", "meta_date_publication": "2008 Aug", "meta_volume": "74", "meta_issue": "4", "meta_pages": "467-77", "score": 50050.734, "text_hl": "Uninephrectomized @SPECIES_10116 @@@rats@@@ developed @DISEASE_Embolism_Fat @DISEASE_MESH:D004620 @@@fat@@@ redistribution and @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@ typical of @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@ when compared with sham-operated @SPECIES_10116 @@@rats@@@ or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-treated uninephrectomized @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Zhao HL, Sui Y, Guan J, He L, Zhu X, Fan RR, Xu G, Kong AP, Ho CS, Lai FM, Rowlands DK, Chan JC, Tong PC. Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int. 2008 Aug;74(4):467-77. PMID: 18496513", "BibTeX": "@article{18496513, title={Fat redistribution and adipocyte transformation in uninephrectomized rats.}, author={Zhao HL and Sui Y and Guan J and He L and Zhu X and Fan RR and Xu G and Kong AP and Ho CS and Lai FM and Rowlands DK and Chan JC and Tong PC}, journal={Kidney Int}, volume={74}, number={4}, pages={467-77}}"}}, {"_id": "11329151", "pmid": 11329151, "title": "Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.", "journal": "J Pathol", "authors": ["Smit-van Oosten A", "Navis G", "Stegeman CA", "Joles JA", "Klok PA", "Kuipers F", "Tiebosch AT", "van Goor H"], "date": "2001-05-01T00:00:00Z", "doi": "10.1002/1096-9896(200105)194:1<122::AID-PATH859>3.0.CO;2-T", "meta_date_publication": "2001 May", "meta_volume": "194", "meta_issue": "1", "meta_pages": "122-9", "score": 50049.164, "text_hl": "This study examines the long-term (34 weeks) effects of the @GENE_ACE @GENE_24310 @@@angiotensin-converting enzyme@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and the angiotensin II receptor type I blocker @CHEMICAL_L_158809 @CHEMICAL_MESH:C070967 @@@L158,809@@@ in the Fisher to Lewis @SPECIES_10116 @@@rat@@@ model of @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal transplant failure@@@. ", "citations": {"NLM": "Smit-van Oosten A, Navis G, Stegeman CA, Joles JA, Klok PA, Kuipers F, Tiebosch AT, van Goor H. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. J Pathol. 2001 May;194(1):122-9. PMID: 11329151", "BibTeX": "@article{11329151, title={Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.}, author={Smit-van Oosten A and Navis G and Stegeman CA and Joles JA and Klok PA and Kuipers F and Tiebosch AT and van Goor H}, journal={J Pathol}, volume={194}, number={1}, pages={122-9}}"}}, {"_id": "15250920", "pmid": 15250920, "title": "Drug therapy for hypertension in hemodialysis patients.", "journal": "Semin Dial", "authors": ["Hörl MP", "Hörl WH"], "date": "2004-07-01T00:00:00Z", "doi": "10.1111/j.0894-0959.2004.17329.x", "meta_date_publication": "2004 Jul-Aug", "meta_volume": "17", "meta_issue": "4", "meta_pages": "288-94", "score": 50042.64, "text_hl": "Nonselective beta-blockers can cause an increase in serum @CHEMICAL_Potassium @CHEMICAL_MESH:D011188 @@@potassium@@@ (particularly during fasting or exercise). @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ have a predominant renal excretion and therefore a prolonged half life in @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@ESRD@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Hörl MP, Hörl WH. Drug therapy for hypertension in hemodialysis patients. Semin Dial. 2004 Jul-Aug;17(4):288-94. PMID: 15250920", "BibTeX": "@article{15250920, title={Drug therapy for hypertension in hemodialysis patients.}, author={Hörl MP and Hörl WH}, journal={Semin Dial}, volume={17}, number={4}, pages={288-94}}"}}, {"_id": "25531311", "pmid": 25531311, "title": "Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.", "journal": "Nephron", "authors": ["Gentile G", "Remuzzi G", "Ruggenenti P"], "date": "2015-01-01T00:00:00Z", "doi": "10.1159/000368331", "meta_date_publication": "2015", "meta_volume": "129", "meta_issue": "1", "meta_pages": "39-41", "score": 50042.2, "text_hl": "The VA NEPHRON D study found that @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ combination therapy reduced by 34% the risk of predefined reductions in estimated glomerular filtration rate, @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@ESRD@@@ or @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ as compared to @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ in 1,448 @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ @SPECIES_9606 @@@patients@@@ with overt @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@. ", "citations": {"NLM": "Gentile G, Remuzzi G, Ruggenenti P. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny. Nephron. 2015;129(1):39-41. PMID: 25531311", "BibTeX": "@article{25531311, title={Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.}, author={Gentile G and Remuzzi G and Ruggenenti P}, journal={Nephron}, volume={129}, number={1}, pages={39-41}}"}}, {"_id": "28577742", "pmid": 28577742, "title": "Dual renin-angiotensin system blockade for nephroprotection.", "journal": "Nephrol Ther", "authors": ["Ruggenenti P"], "date": "2017-04-01T00:00:00Z", "doi": "10.1016/j.nephro.2017.02.006", "meta_date_publication": "2017 Apr", "meta_volume": "13 Suppl 1", "meta_issue": "", "meta_pages": "S43-S45", "score": 50041.266, "text_hl": "However, the VA NEPHRON D study found that @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ combination therapy reduced by 34 % the risk of pre-defined reductions in estimated glomerular filtration rate, @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@end-stage renal disease@@@ or @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ as compared to @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ in 1448 @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ @SPECIES_9606 @@@patients@@@ with overt @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@. ", "citations": {"NLM": "Ruggenenti P. Dual renin-angiotensin system blockade for nephroprotection. Nephrol Ther. 2017 Apr;13 Suppl 1():S43-S45. PMID: 28577742", "BibTeX": "@article{28577742, title={Dual renin-angiotensin system blockade for nephroprotection.}, author={Ruggenenti P}, journal={Nephrol Ther}, volume={13 Suppl 1}, pages={S43-S45}}"}}]}